Related Experiment Videos
Immunotherapy for scorpion envenoming in Brazil
N A Rezende1, C F Amaral, L Freire-Maia
1Departamento de Clínica Médica, Faculdade de Medicina, UFMG, Belo Horizonte, Brazil.
Summary
Early intravenous immunotherapy is crucial for treating Tityus serrulatus scorpion stings. Prompt administration of antivenom effectively neutralizes venom and resolves symptoms, significantly reducing mortality rates.
Area of Science:
- Toxicology
- Pharmacology
- Immunology
Background:
- Tityus serrulatus scorpion venom exhibits rapid absorption, tissue distribution, and slow elimination.
- Understanding venom pharmacokinetics is essential for effective envenoming treatment.
Purpose of the Study:
- To evaluate the pharmacokinetic properties of Tityus serrulatus scorpion venom in rats.
- To assess the efficacy of intravenous antivenom immunotherapy in neutralizing venom and alleviating symptoms.
Main Methods:
- Enzyme-Linked Immunosorbent Assay (ELISA) was used to quantify venom and antivenom levels.
- Pharmacokinetic parameters (absorption, distribution, elimination) of venom were determined.
- Clinical symptoms and antivenom efficacy were monitored post-immunotherapy.
Main Results:
- Scorpion venom demonstrated fast absorption, high tissue distribution, and slow elimination in rats.
- Intravenous antivenom (Fab2 fragment) rapidly cleared plasma venom antigens within 1 hour.
- High antivenom concentrations persisted for at least 24 hours, confirming neutralization efficacy.
- Symptom resolution occurred within 1 to 48 hours post-immunotherapy.
Conclusions:
- Intravenous immunotherapy for Tityus serrulatus envenoming should be administered as early as possible.
- A tripartite approach combining symptomatic care, vital function support, and serotherapy is highly effective.
- This comprehensive treatment strategy resulted in a very low mortality rate (0.28%).